Headlines in Dermatology Health Canada Accepts Arcutis’ SNDS for Roflumilast Foam 0.3% for Scalp and Body PsO
Headlines in Dermatology Dermata, Revance Partner to Study Topical Application of Xyngari With Daxxify for Primary Axillary Hyperhidrosis
